Assembly Biosciences (ASMB) Assets (2010 - 2026)
Assembly Biosciences (ASMB) recorded Assets of $330.83 million in Q2 2026, up 309.5% from $80.78 million a year earlier and up 40.5% from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assembly Biosciences reported Assets of $257.59 million, up 116.2% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
- Across earlier years, Assets came in at $119.17 million in FY2024 (-12.9%), $136.82 million in FY2023 (+34.4%), $101.79 million in FY2022 (-46.7%) and $191.06 million in FY2021 (-32.5%).
- The Q2 2026 figure is the highest quarterly Assets since Q4 2019.
- On a year-over-year basis, Assets has increased for four consecutive quarters, with growth averaging 92.1% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 309.5% in Q2 2026, against a decline of 57.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $235.51 million (Q1 2026), $257.59 million (Q4 2025) and $240 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Assembly Biosciences | 468.67 Mn | -558.96 Mn | - | 330.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 330.83 Mn |
| Mar 31, 2026 | 235.51 Mn |
| Dec 31, 2025 | 257.59 Mn |
| Sep 30, 2025 | 240.00 Mn |
| Jun 30, 2025 | 80.78 Mn |
| Mar 31, 2025 | 99.02 Mn |
| Dec 31, 2024 | 119.17 Mn |
| Sep 30, 2024 | 100.26 Mn |
| Jun 30, 2024 | 115.32 Mn |
| Mar 31, 2024 | 119.88 Mn |
| Dec 31, 2023 | 136.82 Mn |
| Sep 30, 2023 | 51.63 Mn |
| Jun 30, 2023 | 66.58 Mn |
| Mar 31, 2023 | 83.12 Mn |
| Dec 31, 2022 | 101.79 Mn |
| Sep 30, 2022 | 121.52 Mn |
| Jun 30, 2022 | 143.45 Mn |
| Mar 31, 2022 | 162.73 Mn |
| Dec 31, 2021 | 191.06 Mn |
| Sep 30, 2021 | 248.97 Mn |
API Access
Assembly Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();